Related Experiment Video
Updated: Aug 15, 2026

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
Published on: March 16, 2018
Ototoxicity: therapeutic opportunities
Leonard P Rybak1, Craig A Whitworth
1Department of Surgery, Southern Illinois University, School of Medicine, P.O. Box 19653, Springfield, IL 62794-9653, USA. lrybak@siumed.edu
Abstract:
Two major classes of drugs currently in clinical use can cause permanent hearing loss. Aminoglycoside antibiotics have a major role in the treatment of life-threatening infections and platinum-based chemotherapeutic agents are highly effective in the treatment of malignant disease. Both damage the hair cells of the inner ear, resulting in functional deficits. The mechanisms underlying these troublesome side effects are thought to involve the production of reactive oxygen species in the cochlea, which can trigger cell-death pathways. One strategy to protect the inner ear from ototoxicity is the administration of antioxidant drugs to provide upstream protection and block the activation of cell-death sequences. Downstream prevention involves the interruption of the cell-death cascade that has already been activated, to prevent apoptosis. Challenges and opportunities exist for appropriate drug delivery to the inner ear and for avoiding interference with the therapeutic efficacy of both categories of ototoxic drugs.
Insights
Aminoglycoside antibiotics and platinum chemotherapy cause hearing loss by damaging inner ear hair cells. Antioxidant strategies aim to protect against this ototoxicity, but drug delivery and efficacy remain challenges.
Area of Science:
- Ototoxicity research
- Pharmacology
- Cell biology
Background:
- Aminoglycoside antibiotics and platinum-based chemotherapy are crucial drugs with ototoxicity as a significant side effect.
- These drugs damage cochlear hair cells, leading to permanent hearing loss.
- Reactive oxygen species (ROS) are implicated in the cell-death pathways activated by these drugs.
Purpose of the Study:
- To explore strategies for preventing drug-induced hearing loss (ototoxicity).
- To investigate the role of reactive oxygen species in ototoxicity.
- To evaluate antioxidant and anti-apoptotic approaches for inner ear protection.
Main Methods:
- Review of existing literature on ototoxicity mechanisms.
- Analysis of antioxidant and downstream apoptosis inhibition strategies.
- Discussion of drug delivery challenges to the inner ear.
Main Results:
- Ototoxicity is mediated by reactive oxygen species, triggering cell-death cascades.
- Antioxidant administration offers upstream protection against ototoxicity.
- Downstream interruption of apoptosis can prevent further cell death.
Conclusions:
- Protecting the inner ear from ototoxicity requires addressing reactive oxygen species and cell-death pathways.
- Effective drug delivery to the cochlea is critical for therapeutic success.
- Balancing ototoxicity prevention with the efficacy of essential antibiotics and chemotherapeutics is a key challenge.
More Related Videos
12:21The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration
Published on: November 26, 2015
09:18A Comparative Study of Drug Delivery Methods Targeted to the Mouse Inner Ear: Bullostomy Versus Transtympanic Injection
Published on: March 8, 2017
Related Concept Videos
Pharmaceutical Poisoning: Treatment Strategies
Therapeutic Drug Monitoring: Overview and Classification
Drug Toxicity: Overview
Heart Failure Drugs: Inotropic Agents
Drug Toxicity: Dose-Dependent Reactions
Therapeutic Drug Monitoring: Affecting Factors